RecruitingNCT03362658

Novel MRI Biomarkers for Monitoring Disease Progression in ALS

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Alberta
Principal Investigator
Sanjay Kalra, MD
FRCPC
Enrollment
700 enrolled
Eligibility
18 years · All sexes
Timeline
20162025

Study locations (9)

Collaborators

University of Calgary · Western University, Canada · McGill University · University of Toronto · University of British Columbia · Laval University · University of Miami · University of Utah

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03362658 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis

← Back to all trials